TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 125 filers reported holding TREACE MED CONCEPTS INC in Q1 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $223 | -100.0% | 17 | -100.0% | 0.00% | -100.0% |
| Q2 2023 | $7,244,024 | -13.2% | 283,191 | -14.5% | 0.01% | -12.5% |
| Q1 2023 | $8,343,655 | +8.5% | 331,229 | -1.0% | 0.02% | 0.0% |
| Q4 2022 | $7,691,118 | -7.7% | 334,542 | -11.4% | 0.02% | -11.1% |
| Q3 2022 | $8,334,000 | – | 377,682 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXT CENTURY GROWTH INVESTORS LLC | 1,537,271 | $38,723,856 | 4.26% |
| Millrace Asset Group, Inc. | 72,595 | $1,829 | 2.13% |
| Divisadero Street Capital Management, LP | 175,000 | $4,408,250 | 1.93% |
| Perceptive Advisors | 2,442,250 | $61,520,278 | 1.82% |
| SECTORAL ASSET MANAGEMENT INC | 366,443 | $9,230,699 | 1.77% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,120,875 | $28,234,841 | 1.67% |
| EMERALD ADVISERS, LLC | 1,363,453 | $34,345,381 | 1.65% |
| FORMULA GROWTH LTD | 124,900 | $3,146,231 | 1.01% |
| Novo Holdings A/S | 540,000 | $13,602,600 | 0.90% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 755,379 | $19,027,997 | 0.78% |